Abstract: The present invention is directed to novel heterocycle derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.
Type:
Grant
Filed:
May 27, 2008
Date of Patent:
August 24, 2010
Assignee:
J & J Pharmaceutical Research & Development, LLC.